Monograph Capital Holdings Advisors LLC 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-04 08:56 am Purchase |
2023-07-26 | 13D | UroGen Pharma Ltd. URGN |
Monograph Capital Holdings Advisors LLC | 1,662,327 5.400% |
1,662,327 (New Position) |
Filing |